I won’t spend much time arguing on this point KF. Conceded.
However as to lack of interest and patents on DC technology, that is not true. I know of multiple under the radar efforts right now that have been going on for years at top research institutions utilizing very similar technology and actually getting encouraging results. Additionally in my own research on the patents I discovered that a good friend who is a top cancer researcher, who knows Dr. Liau well from medical training years has a DC patent.
People continue to rack up patents on obscure and useful topics all the time. There are lots of research areas and DC cells are a well researched and critical area of immune therapy research. By far NWBO is not the only interested party. But I will say that much of the research is happening at via research hospitals and universities still and is therefore mostly off the radar of investors.